FGFR1 and triple-negative breast carcinoma: However, FGFR1 expression is associated with unfavorable outcomes in other tumors, including lung cancer, triple-negative breast cancer, and gastric cancer, and FGFR1 may be a useful therapeutic target in these diseases [12, 14, 15].